Feb 2019
KNOWLEDGE AND ATTITUDES OF AUSTRALIAN GENERAL PRACTITIONERS TOWARDS MEDICINAL CANNABIS: A CROSS-SECTIONAL SURVEY
Emily A Karanges, Anastasia Suraev, Natalie Elias, Ramesh Manocha, Iain S McGregor.
BMJ Open: 10.1136/bmjopen-2018-022101, 3 July 2018.
The aim of the survey completed by 640 Australian general practitioners (GP) was to examine the knowledge and attitudes of GP towards medicinal cannabis. The results show that the majority of surveyed practitioners are supportive or neutral when it comes to medicinal cannabis use. The survey also highlights the need for additional, improved training for GPs around treating with medicinal cannabis.
Pre-clinical studies documenting the anti-cancer effects of THC and its success in inhibiting cancer growth and spread have been on the rise. Clinical studies however are scarce as the psychoactive effects of THC can limit its medicinal and clinical use. Could non-psychoactive cannabinoids found in cannabis and hemp be the answer to treating cancer instead?
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.